(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.48%) $79.64
(0.61%) $2.32
(0.60%) $2 354.40
(0.69%) $28.56
(0.45%) $995.30
(0.04%) $0.928
(-0.15%) $10.85
(0.03%) $0.799
(0.01%) $92.55
Live Chart Being Loaded With Signals
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases...
Stats | |
---|---|
Dagens volum | 60 973.00 |
Gjennomsnittsvolum | 72 026.00 |
Markedsverdi | 10.21M |
EPS | $0 ( 2024-04-04 ) |
Neste inntjeningsdato | ( $-0.780 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.860 |
ATR14 | $0.0210 (1.35%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Biotech Target N V | Buy | 250 000 | Common Stock |
2024-04-02 | Biotech Target N V | Buy | 769 334 | Common Warrants (right to buy) |
2024-04-02 | Biotech Target N V | Buy | 134 667 | Prefunded Warrants (right to buy) |
2024-04-02 | Lalande Kevin M. | Buy | 1 154 154 | Warrants (Right to Buy) |
2024-04-02 | Lalande Kevin M. | Buy | 402 077 | Pre-Funded Warrants (Right to Buy) |
INSIDER POWER |
---|
99.95 |
Last 98 transactions |
Buy: 16 322 736 | Sell: 222 785 |
Volum Korrelasjon
Molecular Templates Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
JRJC | 0.967 |
WKSP | 0.946 |
ARKO | 0.945 |
AZYO | 0.944 |
RGF | 0.943 |
CPSH | 0.942 |
PHCF | 0.934 |
RETO | 0.934 |
GETVV | 0.929 |
AZ | 0.928 |
10 Mest negative korrelasjoner | |
---|---|
VITL | -0.953 |
DXPE | -0.945 |
NGMS | -0.942 |
PATI | -0.94 |
CRDF | -0.94 |
RXDX | -0.939 |
QADB | -0.935 |
ALBO | -0.935 |
MIRO | -0.934 |
CPTA | -0.934 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Molecular Templates Inc Korrelasjon - Valuta/Råvare
Molecular Templates Inc Økonomi
Annual | 2023 |
Omsetning: | $57.31M |
Bruttogevinst: | $50.40M (87.94 %) |
EPS: | $-1.800 |
FY | 2023 |
Omsetning: | $57.31M |
Bruttogevinst: | $50.40M (87.94 %) |
EPS: | $-1.800 |
FY | 2022 |
Omsetning: | $19.75M |
Bruttogevinst: | $11.95M (60.51 %) |
EPS: | $-24.69 |
FY | 2021 |
Omsetning: | $38.70M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $1.690 |
Financial Reports:
No articles found.
Molecular Templates Inc
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.